pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
MIIST-305
Gastrointestinal Radiation Toxicity
Synedgen Inc
0 catalysts
MILRINONE LACTATE IN 5% DEXTROSE
MILRINONE LACTATE IN 5% DEXTROSE (MILRINONE LACTATE IN 5% DEXTROSE)
CAPLIN
0 catalysts
MILRINONE LACTATE IN DEXTROSE
MILRINONE LACTATE IN DEXTROSE (MILRINONE LACTATE IN DEXTROSE)
HIKMA FARMACEUTICA
0 catalysts
MINOXIDIL TOPICAL SOLUTION, 5%
MINOXIDIL TOPICAL SOLUTION, 5% (MINOXIDIL SOLUTION)
TARO
0 catalysts
← prev
page 124 of 271
next →
131
Pain89
Neurology1
MINZOYA
MINZOYA (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS BISGLYCINATE)
Lupin Ltd
0 catalysts
Preclinical
MIRA-55
Anxiety Disorders
$MIRAMIRA PHARMACEUTICALS, INC.
0 catalysts
MIRABEGRON
MIRABEGRON (MIRABEGRON)
Lupin Ltd
0 catalysts
Marketed
MIRTAZAPINE
MIRTAZAPINE (MIRTAZAPINE)
Major Depressive Disorder
Annora Pharma Pvt Ltd
0 catalysts
Phase 2
MIT-001
Oral Mucositis
MitoImmune Therapeutics Inc
0 catalysts
MITOXANTRONE
MITOXANTRONE (MITOXANTRONE)
HOSPIRA
0 catalysts
Phase 2
MIV-711
Osteoarthritis
Medivir AB
0 catalysts
MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT
MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE)
SpecGx LLC
0 catalysts
Phase 3
MK-1406
Pandemic Influenza
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
MK-2214
Alzheimer's Disease
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
MK-3795
Von Hippel-Lindau Syndrome
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
MK-6194
Ulcerative Colitis
$MRKMerck & Co., Inc.
0 catalysts
Marketed
ML-061
Docivyx (docetaxel)
Adenocarcinoma Of The Gastroesophageal Junction
Meridian Laboratories Inc
0 catalysts
Preclinical
MLN-33
Melanoma
$CNBXCNBX Pharmaceuticals Inc.
0 catalysts
Phase 2
MNV-101
Pearson Syndrome
Minovia Therapeutics Ltd
0 catalysts
Phase 2
MNV-201
Pearson Syndrome
Minovia Therapeutics Ltd
0 catalysts
Phase 1
MO-03
Metastatic Renal Cell Carcinoma
Osel Inc
0 catalysts
Phase 1
MOMA-313
Metastatic Breast Cancer
Moma Therapeutics Inc
0 catalysts
Preclinical
MOMA-989
Unspecified Cancer
Moma Therapeutics Inc
0 catalysts
MOMETASONE FUROATE MONOHYDRATE
MOMETASONE FUROATE MONOHYDRATE (MOMETASONE FUROATE MONOHYDRATE)
AUROBINDO PHARMA
0 catalysts
MONTELUKAST
MONTELUKAST (MONTELUKAST)
MACLEODS PHARMS LTD
0 catalysts
Phase 2
MORF-057
Crohn's Disease (Regional Enteritis)
Eli Lilly and Co
0 catalysts
Marketed
MORPHINE SULFATE
MORPHINE SULFATE (MORPHINE SULFATE)
Pain
Piramal Critical Care Inc
0 catalysts
MOUNJARO
MOUNJARO (TIRZEPATIDE)
1 INDICATIONS AND USAGE MOUNJARO ® is indicated as an adjunct to diet and exe…
Glucagon-like peptide 1 receptorGastric inhibitory polypeptide receptor
$LLYELI LILLY & Co
0 catalysts
MOXIFLOXACIN OPHTHALMIC SOLUTION
MOXIFLOXACIN OPHTHALMIC SOLUTION (MOXIFLOXACIN OPHTHALMIC SOLUTION)
ALEMBIC
0 catalysts
Preclinical
MP-004
Retinitis Pigmentosa (Retinitis)
MIRAMOON Pharma SL
0 catalysts